Navigation Links
CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events
Date:5/25/2011

://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of OPAXIO and tosedostat include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with OPAXIO and tosedostat in particular including, without limitation, the potential failure of OPAXIO to prove safe and effective for the treatment of gliomas, including newly diagnosed high-grade gliomas, the potential failure of tosedostat to prove safe and effective for the treatment of AML, determinations by regulatory, patent, and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing, and selling OPAXIO and tosedostat, that CTI may not be able to obtain FDA and/or European Medicines Agency (the "EMA") approval of pixantrone without conducting an additional clinical trial, that CTI may not be able to obtain FDA and/or approval of pixantrone in the United States or the European Union, that CTI may not be able to FDA and/or EMA approval of pixantrone by year end, that CTI may not be able to obtain FDA approval of pixantrone within six months of resubmission of the NDA, that CTI may not be able to acquire this product candidate, that the product candidate may not activate macrophages and dendritic cells to present foreign antigens to T-killer cells and T-memory cells thus activating a tumor specific immune attack with potential lifelong immunity against the cancer, that the product candidate may not eradicate cancer, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be re
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Raptor Pharmaceuticals Provides Update of Product Programs
5. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
6. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
7. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
11. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... of Directors has approved a share repurchase program. The ... $300 million of Mallinckrodt plc ordinary shares. ... opportunities remain top priorities as we continue to pursue ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 16, 2007 /PRNewswire/ -- Sirion Therapeutics,Inc., an ... received orphan drug designation from the Food,and ... for the treatment of acute herpetic keratitis. ... in Europe under,the brand name of Virgan(R). ...
... out of ten patients taking,once-daily Lialda remained relapse ... D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term phase ... the British Society of Gastroenterology (BSG) meeting,in Glasgow, ... well tolerated in mild to moderate UC,patients. Today, ...
Cached Medicine Technology:Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8
(Date:1/22/2015)... 22, 2015 Liberty University has received accreditation ... program from the Council for Accreditation of Counseling & ... Liberty’s Center for Counseling & Family Studies , is ... the university’s new School of Behavioral Sciences. Prior to the ...
(Date:1/22/2015)... Hawley, PA (PRWEB) January 22, 2015 Woodloch ... Pocono Mountains, has been selected by TripAdvisor as the number ... and the 6th best in the world for their annual ... online travel community . The website is home to ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader ... designers are thrilled to have it lead the wedding dress ... collection of prom dresses for the global market. , “The ... vision and he focuses on continuing the goal of operational ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... great websites with its newest category ... ... Great Consumer Driven Health Plan Websites, ... HealthContent,07 Conference in Philadelphia, the recognition,of the Nation,s Top ... analysis of data using the Healthcare Market Guide, and ...
... Radiation oncologists and urologists at the Kimmel Cancer Center ... have begun using a real-time system to implant radiation-emitting ... is made by Nucletron, a technology company based in ... planning purposes so far, it ultimately will help with ...
... investigations of medications, diet and the molecular understanding of ... disease, and herald a new stage in the management ... in the November 1, 2007 issue of CANCER, a ... Fleshner and Dr. Alexandre Zlotta from the University of ...
... a,statement from Alan Rosenbloom, President of the Alliance for ... 23, New York Times story,entitled, "At Many Homes, More ... analyzed by the New York Times, and noted in ... nation,s long term,care ownership category, and is far from ...
... (p. 51). General Editor,Mary Carmichael profiles four people who, ... working to bring lifesaving vaccines to,children around the world ... 18th century. Working to wipe out the big global ... million lives each,year -- is a doctor who,s making ...
... lens replacement is a cost-effective treatment for aging eyes , , ... long enough, will suffer from a cataract that clouds the ... doctors expect spending on cataract surgery to surge in the ... increase in vision costs among older Americans. , However, it,s ...
Cached Medicine News:Health News:Top Twenty Health Plan Websites Named by TheRatingsGuy.com 2Health News:Top Twenty Health Plan Websites Named by TheRatingsGuy.com 3Health News:Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer 2Health News:Diet and medications may assist prevention of prostate cancer 2Health News:Statement from the Alliance for Quality Nursing Home Care 2Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 2Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 3Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 4Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 5Health News:Cataract Surgery: A Bargain, Despite the Price 2Health News:Cataract Surgery: A Bargain, Despite the Price 3
... Accumedics Electronic Medical Record ... HL7 EDI Interface with ... and provides custom reports. ... Software Interface is Microsoft ...
... EHR is designed to improve the efficiency ... the clinician the ability to capture and ... text, image, audio or video formats. As ... a familiar contemporary windows interface and is ...
Dairylands Health Information Management solutions provides healthcare organizations a suite of integrated applications for managing patient records, optimizing reimbursement and regulatory complianc...
... athenaClinicals was developed expressly to help ... By applying the right combination of ... services, you can be confident your ... What's more, athenaClinicals seamlessly ...
Medicine Products: